The role of dendritic cells in cancer.

The role of dendritic cells in cancer.
Int Rev Cell Mol Biol. 2019;348:123-178
Authors: Lee YS, Radford KJ
Abstract
Cancer immunotherapy harnesses the ability of the immune system to recognize and eliminate cancer. The potent ability of dendritic cells (DCs) to initiate and regulate adaptive immune responses underpins the successful generation of anti-tumor immune responses. DCs are a heterogeneous leukocyte population comprised of distinct subsets that drive specific types of immune responses. Understanding how DCs induce tumor immune responses and the mechanisms adopted by tumors to evade DC surveillance is essential to render immunotherapies more effective. This review discusses current knowledge of the roles played by different DC subsets in human cancer and how these might be manipulated as new immunotherapeutics to improve CD8+ T cell-mediated immune responses, with a particular focus on the conventional type 1 DCs (cDC1).
PMID: 31810552 [PubMed - in process]

Source: International Review of Cell and Molecular Biology - December 9, 2019 Category: Cytology Authors: Lee YS, Radford KJ Tags: Int Rev Cell Mol Biol Source Type: research